imvax.com
This biotech firm specializes in personalized cancer immunotherapies, focusing on autologous cell-based treatm… 🔗
Global Rankeez rank — last updated 01 Nov 2026
Better than 96.8% of the 100,511,422 domains we track
Source breakdown
Rankeez combines several independent public rankings. Here's how imvax.com scores in each:
| Source | Rank |
|---|---|
| Tranco (research-grade ranking, resistant to manipulation) | #3,787,420 |
| CommonCrawl (hyperlink graph) | #6,260,893 |
See how these sources are combined and cross-validated →
Ranking history
imvax.com's rank across 4 monthly snapshots. ▲ improved by 13,896,874 since 2026-07
| Month | Rank |
|---|---|
| 2026-07 | #17,112,373 |
| 2026-08 | #17,105,055 |
| 2026-10 | #2,196,142 |
| 2026-11 | #3,215,499 |
JSON API
{
"imvax.com": 3215499,
"history": {
"2026-07": 17112373,
"2026-08": 17105055,
"2026-10": 2196142,
"2026-11": 3215499
}
}
GET https://rankeez.com/api/imvax.com.json · see API docs →
More about imvax.com
imvax.com — page content & similar sites →
Developing novel patient-specific vaccines and immunotherapy strategies Imvax is a clinical-stage biotechnology company with a unique immunotherapy approach to solid tumors. The approach is an autologous, cell-based treatment that activates the full array
imvax.com — full site profile →
WHOIS, tech stack and extended traffic history for imvax.com.